Validation of a method to assess emphysema severity by spirometry in the COPDGene study

Area of Science:

• Pulmonary Medicine
• Radiology
• Medical Imaging

Background:

• Standard spirometry struggles to differentiate emphysema from airway disease in COPD.
• Accurate identification of the predominant mechanism is crucial for effective COPD management.

Purpose of the Study:

• To validate a novel Emphysema Severity Index (ESI) derived from maximal expiratory flow-volume (MEFV) curves.
• To assess ESI's ability to differentiate emphysema from airway disease using CT imaging.

Main Methods:

• Analysis of MEFV curves from 5930 COPDGene participants with same-day CT scans.
• ESI calculation using FVC, PEF, and FEVs at 25%, 50%, and 75% of FVC.
• Correlation of ESI with CT-derived metrics of emphysema (%pLDA) and airway disease (%fLDA).

Main Results:

• ESI effectively differentiated CT-defined emphysema severity subgroups and correlated strongly with emphysema (%pLDA).
• ESI explained 67% of the variability in CT-measured emphysema.
• Standard spirometry metrics (FEV1, FEV1/FVC) showed weaker correlations with emphysema and could not differentiate disease mechanisms.

Conclusions:

• The validated ESI enhances standard spirometry by enabling discrimination of emphysema as the primary cause of airflow obstruction.
• ESI is a reliable tool for clinical and research use in the general smoking population.
• An online tool is available for applying the ESI methodology.